Exubera - Inhaled Insulin for Type 1 and Type 2 Diabetes

Print

Exubera is an inhaled short-acting insulin preparation indicated for the treatment of type 1 and type 2 diabetes.
 
«Back | Next»

Return to Profile



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area
For every phase of your drug development